VYNE Therapeutics Inc. Annual Interest Expense in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
VYNE Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2022.
  • VYNE Therapeutics Inc. Interest Expense for the quarter ending December 31, 2022 was $0.000.
  • VYNE Therapeutics Inc. Interest Expense for the twelve months ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • VYNE Therapeutics Inc. annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
  • VYNE Therapeutics Inc. annual Interest Expense for 2021 was $5.61M, a 27.8% increase from 2020.
  • VYNE Therapeutics Inc. annual Interest Expense for 2020 was $4.39M, a 377% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 -$5.61M -100% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $5.61M +$1.22M +27.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $4.39M +$3.47M +377% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $921K +$921K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.